SCHEMBL6699343

SCHEMBL6699343

N=C(NCc1cccc2ccccc12)NC(=O)N1CCC(C(N)=O)CC1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.47
KDM4E B2RXH2 3/20 0.47
P2RX7 Q99572 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 1/20 0.44
FAAH O00519 1/20 0.44
TPSAB1 Q15661 1/20 0.44
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
MTNR1A P48039 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
BCHE P06276 1/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6701308 0.88 KDM4E (0.61) EPHX2KDM4EP2RX7HSD17B10LMNA
SCHEMBL6990296 0.83 FAAH (0.55) KDM4EP2RX7HSD17B10LMNAFAAH
SCHEMBL6698763 0.83 MEN1 (0.61) FAAHSMN1; SMN2MEN1KMT2A
SCHEMBL6989152 0.83 FAAH (0.54) KDM4EP2RX7HSD17B10LMNAFAAH
SCHEMBL6698803 0.82 FAAH (0.47) P2RX7FAAHTPSAB1MTNR1AGAA
SCHEMBL6694717 0.78 KDM4E (0.60) KDM4EHSD17B10LMNAFAAHMEN1
SCHEMBL6695899 0.78 KMT2A (0.61) KDM4EHSD17B10LMNAFAAHAPOBEC3A
SCHEMBL6704795 0.76 MEN1 (0.51) P2RX7MTNR1ABCHEMEN1MAPT
SCHEMBL6699018 0.74 FAAH (0.55) KDM4ELMNAFAAHMEN1MAPT
SCHEMBL6698809 0.74 HTR7 (0.68) FAAHGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040044037-A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis HONG YUFENG (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044037-A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis HTR7, HTR1A, HTR2C EPHX2 2485/4885KDM4E 3900/4885P2RX7 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.